StockNews.com upgraded shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday morning. OncoSec Medical Stock Up 0.6 % Shares of ONCS opened at $0.81 on Friday. The stock has a fifty day simple moving average of $1.50 and a […]
Oncosec Medical (ONCS) Receives $3 49M After Selling Net Operating Loss Tax Benefits streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
EWING, N.J. and SAN DIEGO, April 11, 2023 /PRNewswire/ OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient s. | April 11, 2023